Biotech · Private company
EmitBio Inc.
Track this companyFree. Adds EmitBio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- RD-X19COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- RD-X19COVID19ClinicalTrials.gov · fetched Nov 12, 2026
- RD19Respiratory Tract InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- RDX-19Post COVID-19 Condition (PCC)ClinicalTrials.gov · fetched Nov 12, 2026
- ShamCOVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- ShamCOVID19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient SettingNA · TERMINATED · started Oct 30, 2023ClinicalTrials.gov NCT06113679 · fetched Nov 12, 2026
- Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19NA · COMPLETED · started Apr 21, 2023ClinicalTrials.gov NCT05817045 · fetched Nov 12, 2026
- Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19NA · COMPLETED · started Jun 17, 2021ClinicalTrials.gov NCT04966013 · fetched Nov 12, 2026
- Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19NA · COMPLETED · started Nov 18, 2020ClinicalTrials.gov NCT04662671 · fetched Nov 12, 2026
- Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease PathogensNA · COMPLETED · started Aug 31, 2020ClinicalTrials.gov NCT04557826 · fetched Nov 12, 2026